Trust Bio-sonics, Inc.
Trust Bio-sonics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Efficacy of NH002 as a Contrast Agent Administrated Via Intravenous Bolus Injection and Infusion for Subjects Undergoing Cardiac Echocardiography | cardiovascular disorder, heart disorder | Not yet recruiting | Phase 3 | 2026-07-31 | NCT07740421 | |
| Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography | cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-07-09 | NCT06815627 | |
| NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer | Liver Metastasis; Pancreatic Adenocarcinoma Metastatic | Not yet recruiting | Phase 1 | 2026-01-02 | NCT07314385 |